Tramadol Hydrochloride
Product Images NDC 68071-2410

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68071-2410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2410 6)

Label for Tramadol Hydrochloride 100 mg extended-release tablets from NuCare Pharmaceuticals, Inc. The label shows NDC 68071-2410-6 and indicates a package count of 60 tablets. It describes the tablets as circular white to off-white, imprint L010, Rx only. Manufacturer is 3M India Limited Pithampur, with packaging by NuCare Pharmaceuticals, Inc., Ontario, CA. Additional batch and serial number fields, storage instructions, and a warning to keep out of reach of children are visible.*

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of Tramadol Hydrochloride showing its molecular arrangement including a phenyl ring with a methoxy group, cyclohexane ring, hydroxyl group, and dimethylamino side chain with an associated hydrochloride component.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line chart comparing tramadol concentration (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets, 200 mg once daily, and Tramadol Hydrochloride Tablets, 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis represents tramadol concentration.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours for two Tramadol Hydrochloride formulations: 200 mg extended-release tablets taken once daily and 50 mg tablets taken every 6 hours. Concentration values are plotted on the Y-axis and time in hours on the X-axis.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

Line graph depicting the percentage of patients achieving various response thresholds in a Tramadol Hydrochloride Extended-Release Tablets Study 023 for WOMAC pain responder analysis. The graph compares response rates for 100 mg, 200 mg, 300 mg, 400 mg doses, and placebo across different percent improvement from baseline response thresholds.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

Line graph comparing the percentage of patients achieving various levels of response threshold in an arthritis pain intensity study for Tramadol Hydrochloride Extended-Release Tablets versus placebo. The X-axis represents response threshold as percent improvement from baseline, and the Y-axis represents percent of patients achieving response, with Tramadol showing higher response rates than placebo across thresholds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.